GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Remed Co Ltd (XKRX:302550) » Definitions » Equity-to-Asset

Remed Co (XKRX:302550) Equity-to-Asset : 0.68 (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Remed Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Remed Co's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₩40,249 Mil. Remed Co's Total Assets for the quarter that ended in Dec. 2024 was ₩59,063 Mil. Therefore, Remed Co's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was 0.68.

The historical rank and industry rank for Remed Co's Equity-to-Asset or its related term are showing as below:

XKRX:302550' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.33   Med: 0.45   Max: 0.71
Current: 0.68

During the past 8 years, the highest Equity to Asset Ratio of Remed Co was 0.71. The lowest was 0.33. And the median was 0.45.

XKRX:302550's Equity-to-Asset is ranked better than
56.78% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: 0.63 vs XKRX:302550: 0.68

Remed Co Equity-to-Asset Historical Data

The historical data trend for Remed Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remed Co Equity-to-Asset Chart

Remed Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Equity-to-Asset
Get a 7-Day Free Trial 0.34 0.34 0.38 0.56 0.68

Remed Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.50 0.55 0.58 0.68

Competitive Comparison of Remed Co's Equity-to-Asset

For the Medical Devices subindustry, Remed Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Remed Co's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Remed Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Remed Co's Equity-to-Asset falls into.


;
;

Remed Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Remed Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Equity to Asset (A: Dec. 2024 )=Total Stockholders Equity/Total Assets
=40248.542/59062.954
=0.68

Remed Co's Equity to Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

Equity to Asset (Q: Dec. 2024 )=Total Stockholders Equity/Total Assets
=40248.542/59062.954
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Remed Co  (XKRX:302550) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Remed Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Remed Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Remed Co Business Description

Traded in Other Exchanges
N/A
Address
187 Techno 2-ro, No 301-303, Gwanpyeong-dong, Yuseong-gu, Daejeon, KOR, 34025
Remed Co Ltd is a Korean medical equipment manufacturing company. The company is engaged in researching and developing products to treat brain disorders such as depression, anxiety, stroke and Parkin's. It has developed TMS device and is manufacturing pain therapy devices using advanced electromagnetic stimulation, shockwave (RSWT) and laser technologies. Its products offerings include Transcranial Magnetic simulator for brain, Electromagnetic simulators including Salus Talent, Salus Talent A, Salus Talent Pro, and Optimus Pro for pain therapy; and Rosetta, Salus RSWT and Optimus Pro as a part of Extracorporeal Shockwave Therapy. It also offers Electrosurgical units from REMED including ELPIS 4L, ELPIS 4, ELPIS 3, and ELPIS2.

Remed Co Headlines

No Headlines